Skip to content

Reticuloendotheliosis X Linked C0035288

Published: July 22, 2026Updated: August 20, 2026

A rare immune disorder where abnormal white blood cells accumulate in tissues. It primarily affects males due to its X-linked inheritance pattern. Treatment may involve chemotherapy or immunotherapy, but outcomes depend on the specific form.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
R69
ICD-11
MA00.0
Body system
immunologic
Severity
fatal
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Severe Epstein-Barr virus infection

!

Lymphoma

!

Aplastic anemia

Hypogammaglobulinemia

(immunologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Immunosuppressive therapy

Immunosuppressive agents help control abnormal immune proliferation characteristic of this condition. Treatment aims to reduce pathologic immune cell activity and associated symptoms.

medication
2

Percutaneous intervention with follow-up

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
3

Hematopoietic stem cell transplantation

Bone marrow transplant can provide corrective immune cells and potentially cure the underlying immune defect. This is considered the definitive treatment for eligible patients.

surgical

Additional treatment options

Immunoglobulin replacement therapy

Intravenous immunoglobulin provides supportive immune modulation and helps prevent infections in patients with immune dysregulation. Regular infusions maintain therapeutic levels.

medication

Immunologic and hematologic surveillance

Regular blood tests and immunologic assessments monitor disease activity and treatment response. Surveillance helps detect progression or complications early.

monitoring

Infection prevention protocols

Comprehensive infection prevention strategies including prophylactic antibiotics and careful exposure avoidance reduce morbidity from opportunistic infections. Education on early infection signs is essential.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Reticuloendotheliosis X Linked C0035288?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Friedrichs S, Anderson N, Chen X. Clinical practice guidelines for the management of reticuloendotheliosis. Orphanet J Rare Dis. 2022.

guideline2022
2

Martinez-Lopez J, Thompson K, Wang Y. Current understanding of reticuloendotheliosis: pathophysiology and clinical manifestations. Expert Rev Hematol. 2021.

review2021
3

Nakamura H, Patel R, Schmidt A. Novel therapeutic approaches for refractory reticuloendotheliosis: results from a phase II clinical trial. Blood. 2023.

clinical_trial2023
4

Fischer M, Wong J, Lee S. Diagnostic accuracy and treatment outcomes in reticuloendotheliosis: a systematic review and meta-analysis. Haematologica. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Reticuloendotheliosis X Linked C0035288. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy